Spectrum Pharmaceuticals appoints chief medical officer
Insight Weekly: Loan delinquencies up; US money supply falls; coal employment grows
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Spectrum Pharmaceuticals Inc. said it appointed Francois Lebel as chief medical officer, effective Nov. 5.
Most recently, Lebel served as the executive vice president of research and development and chief medical officer at ZIOPHARM Oncology Inc.
Henderson, Nev.-based Spectrum Pharmaceuticals is a biopharmaceutical company that develops and commercializes oncology and hematology drug products.
